EBS Emergent BioSolutions Inc.
NYSE · SEC CIK 1367644 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.42M 10 sales by 7 insiders
- Filings on record
- 205 since 2021-11-15, latest 2026-07-02 12:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| DeGolyer Donald W | Dir | — | $317.6K |
| Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| Richard Ronald | Dir | — | $263.1K |
| Dayal Sujata Tyagi | Dir | — | $201.1K |
| Zoon Kathryn C | Dir | — | $144.5K |
| Katkin Keith | Dir | — | $128.2K |
| Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| Lowry Simon C | SVP, CMO, R, D | — | — |
| Perl Jessica | SVP, GC, Corp Sec | — | — |
| Hartzel William | SVP, Bioservices | — | — |
Transactions 225
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-02 | 2022-03-01 | EBS | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +48.3K | 86.3K | +127% | $0 |
| D | 2022-03-02 | 2022-02-28 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $39.64 | -818 | 85.5K | -0.9% | -$32.4K |
| DM | 2022-03-02 | 2022-03-01 | EBS | Kramer Robert | Pres, CEO, Dir | A - Grant | $0.00 | +89.4K | 193.1K | +86% | $0 |
| D | 2022-03-02 | 2022-02-28 | EBS | Kramer Robert | Pres, CEO, Dir | F - Tax | $39.64 | -1,715 | 247.0K | -0.7% | -$68.0K |
| D | 2022-03-02 | 2022-02-28 | EBS | Havey Adam | EVP, Business Ops | F - Tax | $39.64 | -739 | 86.2K | -0.9% | -$29.3K |
| DM | 2022-03-02 | 2022-03-01 | EBS | Havey Adam | EVP, Business Ops | A - Grant | $0.00 | +50.1K | 69.1K | +264% | $0 |
| DM | 2022-03-02 | 2022-03-01 | EBS | SARAN ATUL | EVP, Chief Strat, Dev Off | A - Grant | $0.00 | +48.3K | 91.5K | +112% | $0 |
| D | 2022-03-02 | 2022-02-28 | EBS | SARAN ATUL | EVP, Chief Strat, Dev Off | F - Tax | $39.64 | -764 | 90.8K | -0.8% | -$30.3K |
| M | 2022-02-25 | 2022-02-23+ | EBS | SARAN ATUL | EVP, GC, Corp Dev, Sec | F - Tax | $42.39 | -1,299 | 43.2K | -3% | -$55.1K |
| M | 2022-02-25 | 2022-02-23+ | EBS | Kramer Robert | Pres, CEO, Dir | F - Tax | $42.37 | -3,453 | 159.3K | -2% | -$146.3K |
| M | 2022-02-25 | 2022-02-23+ | EBS | Havey Adam | EVP, Business Ops | F - Tax | $42.39 | -1,252 | 37.6K | -3% | -$53.1K |
| M | 2022-02-25 | 2022-02-23+ | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $42.39 | -1,499 | 38.0K | -4% | -$63.5K |
| M | 2022-02-25 | 2022-02-23+ | EBS | Strei Katherine | EVP, Chief HR Off | F - Tax | $42.38 | -934 | 30.2K | -3% | -$39.6K |
| 2022-02-24 | 2022-02-22 | EBS | Kramer Robert | Pres, CEO, Dir | A - Grant | $0.00 | +4,264 | 167.3K | +3% | $0 | |
| 2022-02-24 | 2022-02-22 | EBS | Kramer Robert | Pres, CEO, Dir | F - Tax | $42.23 | -4,595 | 162.7K | -3% | -$194.0K | |
| 2022-02-24 | 2022-02-22 | EBS | Strei Katherine | EVP, Chief HR Off | A - Grant | $0.00 | +1,258 | 32.8K | +4% | $0 | |
| 2022-02-24 | 2022-02-22 | EBS | Strei Katherine | EVP, Chief HR Off | F - Tax | $42.23 | -1,616 | 31.1K | -5% | -$68.2K | |
| 2022-02-24 | 2022-02-22 | EBS | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +1,836 | 41.8K | +5% | $0 | |
| 2022-02-24 | 2022-02-22 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $42.23 | -2,298 | 39.5K | -6% | -$97.0K | |
| 2022-02-24 | 2022-02-22 | EBS | Havey Adam | EVP, Business Ops | F - Tax | $42.23 | -1,980 | 38.0K | -5% | -$83.6K | |
| 2022-02-24 | 2022-02-22 | EBS | Havey Adam | EVP, Business Ops | A - Grant | $0.00 | +1,836 | 40.0K | +5% | $0 | |
| 2022-02-24 | 2022-02-22 | EBS | SARAN ATUL | EVP, GC, Corp Dev, Sec | F - Tax | $42.23 | -2,084 | 44.5K | -4% | -$88.0K | |
| 2022-02-24 | 2022-02-22 | EBS | SARAN ATUL | EVP, GC, Corp Dev, Sec | A - Grant | $0.00 | +1,836 | 46.6K | +4% | $0 | |
| MI | 2021-12-07 | 2021-12-03 | EBS | El-Hibri Fuad | Dir | J - Other | $0.00 | +3.50M | 3.02M | New | $0 |
| 2021-11-15 | 2021-11-15 | EBS | LINDAHL RICHARD S | EVP, CFO | P - Purchase | $37.46 | +3,000 | 39.9K | +8% | +$112.4K |
Purchase Sale Sale after option exercise All abbreviations